Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Tiotropium + olodaterol fixed-dose combination shows clinically meaningful improvements in quality of life versus placebo

Dave Singh, Gary T. Ferguson, Josef Bolitschek, Lars Grönke, Christoph Hallmann, Nathan Bennett, Roger Abrahams, Olaf Schmidt, Leif Bjermer
European Respiratory Journal 2015 46: PA2958; DOI: 10.1183/13993003.congress-2015.PA2958
Dave Singh
1The Medicines Evaluation Unit (MEU), University Hospital of South Manchester, Manchester, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gary T. Ferguson
2Pulmonary Research, Institute of Southeast Michigan, Livonia, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Josef Bolitschek
3Department of Pneumology, Krankenhaus der Elisabethinen, Linz, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lars Grönke
4Medical Affairs Department, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christoph Hallmann
4Medical Affairs Department, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nathan Bennett
5Statistics Department, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roger Abrahams
6Department of Clinical Research, Morgantown Pulmonary Associates, Morgantown, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olaf Schmidt
7Lungen- und Bronchialheilkunde, KPPK Studienzentrum, Koblenz, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leif Bjermer
8Department of Respiratory Medicine and Allergology, Lund University, Lund, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Information

vol. 46 no. suppl 59
DOI 
https://doi.org/10.1183/13993003.congress-2015.PA2958

Published By 
European Respiratory Society
Print ISSN 
0903-1936
Online ISSN 
1399-3003
History 
  • Published online October 30, 2015.

Copyright & Usage 
Copyright ©ERS 2015

Author Information

  1. Dave Singh1,
  2. Gary T. Ferguson2,
  3. Josef Bolitschek3,
  4. Lars Grönke4,
  5. Christoph Hallmann4,
  6. Nathan Bennett5,
  7. Roger Abrahams6,
  8. Olaf Schmidt7 and
  9. Leif Bjermer8
  1. 1The Medicines Evaluation Unit (MEU), University Hospital of South Manchester, Manchester, United Kingdom
  2. 2Pulmonary Research, Institute of Southeast Michigan, Livonia, United States
  3. 3Department of Pneumology, Krankenhaus der Elisabethinen, Linz, Austria
  4. 4Medical Affairs Department, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany
  5. 5Statistics Department, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, United States
  6. 6Department of Clinical Research, Morgantown Pulmonary Associates, Morgantown, United States
  7. 7Lungen- und Bronchialheilkunde, KPPK Studienzentrum, Koblenz, Germany
  8. 8Department of Respiratory Medicine and Allergology, Lund University, Lund, Sweden

Article usage

Article usage: November 2015 to December 2022

AbstractFullPdf
Nov 2015900
Dec 20153800
Jan 20163400
Feb 20162300
Mar 20163101
Apr 20161000
May 20165100
Jun 20163500
Jul 20162100
Aug 20162200
Sep 201624016
Oct 20162200
Nov 20161400
Dec 20161700
Jan 20172300
Feb 20171600
Mar 20171800
Apr 20171700
May 20173800
Jun 20172800
Jul 20173300
Aug 20171000
Sep 20172800
Oct 20171700
Nov 20172000
Dec 20172600
Jan 20183100
Feb 20182400
Mar 20182000
Apr 2018700
May 20182000
Jun 20181900
Jul 20182300
Aug 20181000
Sep 20181400
Oct 20181800
Nov 20182400
Dec 2018900
Jan 20192300
Feb 20191600
Mar 20193100
Apr 2019800
May 20191100
Jun 20191400
Jul 20192500
Aug 20191900
Sep 20191100
Oct 20191600
Nov 20191800
Dec 20192500
Jan 20202200
Feb 20201800
Mar 20202500
Apr 20201600
May 20201600
Jun 20201000
Jul 20202500
Aug 2020900
Sep 20201100
Oct 20201700
Nov 20201900
Dec 20202000
Jan 20211800
Feb 2021400
Mar 20211000
Apr 20211900
May 20211200
Jun 20211800
Jul 20211300
Aug 20211100
Sep 20212200
Oct 20212100
Nov 20213100
Dec 20211300
Jan 20222300
Feb 20221100
Mar 2022700
Apr 20221700
May 20221300
Jun 2022800
Jul 2022400
Aug 2022500
Sep 2022800
Oct 2022700
Nov 2022700
Dec 2022300

Altmetrics

Previous
Back to top
Vol 46 Issue suppl 59 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Tiotropium + olodaterol fixed-dose combination shows clinically meaningful improvements in quality of life versus placebo
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Tiotropium + olodaterol fixed-dose combination shows clinically meaningful improvements in quality of life versus placebo
Dave Singh, Gary T. Ferguson, Josef Bolitschek, Lars Grönke, Christoph Hallmann, Nathan Bennett, Roger Abrahams, Olaf Schmidt, Leif Bjermer
European Respiratory Journal Sep 2015, 46 (suppl 59) PA2958; DOI: 10.1183/13993003.congress-2015.PA2958

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Tiotropium + olodaterol fixed-dose combination shows clinically meaningful improvements in quality of life versus placebo
Dave Singh, Gary T. Ferguson, Josef Bolitschek, Lars Grönke, Christoph Hallmann, Nathan Bennett, Roger Abrahams, Olaf Schmidt, Leif Bjermer
European Respiratory Journal Sep 2015, 46 (suppl 59) PA2958; DOI: 10.1183/13993003.congress-2015.PA2958
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Figures & Data
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Dysphonia in asthmatic women using inhaled corticosteroids: It is not only a laryngeal inflammation
  • A fixed combination of thyme and primula dry extracts normalizes goblet cell hyperplasia and MUC5AC formation in vivo and in vitro
  • Prostacyclin IP receptor activation blocks hyperosmolar-induced bronchoconstriction in isolated human small airways
Show more 5.1 Airway Pharmacology and Treatment

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society